Gilead Sciences (GILD)
$68.28 0.10 (0.15%)
10:06 EDT GILD Stock Quote Delayed 30 Minutes
Previous Close $68.18
Market Cap 88.78B
PE Ratio 25.96
Volume (Avg. Vol.) 1.08M
Day's Range 68.00 - 68.48
52-Week Range 60.89 - 85.97
Dividend & Yield 2.23 (3.27%)
GILD Stock Predictions, Articles, and Gilead Sciences News
- From InvestorPlace
- From the Web
Stocks slipped, but didn't plummet in the stock market today despite a horrendous jobs report that highlight the impact of Covid-19.
Gilead Sciences is working on a coronavirus treatment, while GILD stock works on a breakout. Let's examine it more closely.
Gilead Science’s clinical trial for remdesivir continues. With or without it, GILD stock remains a smart play.
These biotech stocks are all working on treatments that have the potential to beat the coronavirus. Don't just wait for a cure. Buy them now.
Looking for hot stocks for 2020? These five stocks in particular have steadily outperformed the broader market during the coronavirus crisis.
Gilead Sciences rose to prominence with its hepatitis C drug. Now GILD stock is soaring on hopes for a coronavirus treatment.
Healthcare stocks lead the way higher on Monday, as equities added another gain to the recent run. Here's the stock market today.
Once touted as a direct coronavirus play, GILD stock is now receiving heat due to a PR nightmare. But this unfortunate development ultimately won’t affect the bigger picture.
GILD stock could skyrocket if it is first in the door to provide an effective treatment for the coronavirus with its remdesivir drug.
Remdesivir appears to have helped coronavirus patients, and the drug looks poised to boost GILD stock.
Stocks hit new 52-week lows in the stock market today, as equities continue to free-fall on coronavirus-related worries.
While coronavirus fears have killed the stock market this year, these nine best stocks for 2020 have bucked the trend.
Gilead Sciences has scored a lot of attention with its drug that may treat coronavirus. That doesn't necessarily make GILD stock a buy yet, though.
GT Biopharma (GTBP) news for Tuesday about it working on a possible treatment for the coronavirus from China has GTBP stock heading higher.
There's a good chance that Gilead's drug will become the coronavirus vaccine, making Gilead stock attractive.
The VIX topped $50 and hit its highest level in a decade. Here's what else happened in the stock market today.
Advanced Micro Devices, Walmart, Gilead Sciences and Salesforce were our top stock trades for Monday. That said, here's a look at the charts.
INO stock has screamed higher on the possibility of a coronavirus vaccine but the underlying company isn't the most fiscally stable.
After 20 years of hiring, these are the 6 biggest LinkedIn mistakes—and examples of how to really stand out
Latest Research Study on Global E-Learning Services Market published by AMA, offers a detailed overview of the factors influencing the global business scope. Global E-Learning Services Market research report shows the latest market insights with upcoming trends and breakdown of the products and services
Navellier RatingsPowered by Portfolio Grader